Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Ensysce Biosciences Regains Full Compliance with Nasdaq
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Regains Full Compliance with Nasdaq

December 23, 2024 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on December 20, 2024, it received notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has demonstrated compliance with the minimum bid price requirement in Listing Rule 5550(a)(2). Ensysce...

Read more
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease

December 23, 2024 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is a promising development as the company explores Telomir-1 for the treatment of Wilson's disease and other copper related disorders. The announcement marks an important step forward in Telomir's mission to address critical unmet medical needs while...

Read more
Global Digital Stethoscope Market Poised for Robust Growth, Expected to Reach USD 539.6 Million by 2034 | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Global Digital Stethoscope Market Poised for Robust Growth, Expected to Reach USD 539.6 Million by 2034 | Future Market Insights, Inc.

December 23, 2024 7:30 AM

The digital stethoscope market is expected to be valued at USD 310.0 million in 2024. Projections indicate robust growth persisting from 2024 to 2034 at a commendable CAGR of 5.7%. By 2034, the market value is forecasted to hit USD 539.6 million.Healthcare is rapidly transitioning into the digital sphere as hospitals and other diagnostic centers undergo modernization. As part of this digitization trend, digital stethoscopes are increasingly...

Read more
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Healthcare & PharmaceuticalCompany Update

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone

December 23, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the launch of two new canine assays for the TRUFORMA In-Clinic Biosensor Testing Platform.Zomedica's canine NT-poBNP test is used for the quantitative detection of NT-proBNP in canine EDTA plasma...

Read more
NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
Healthcare & PharmaceuticalCompany Update

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

December 23, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential bird flu pandemic because the mercurial H5N1 Influenza A virus would not be able to escape the drug."Despite all changes, the H5N1 Influenza A virus should remain susceptible to NV-387 because NV-387 mimics the very essential host-side feature that H5N1 continues to use even as it...

Read more
Ascelia Pharma Patent Granted in China for Second Generation Orviglance
Healthcare & PharmaceuticalCompany Update

Ascelia Pharma Patent Granted in China for Second Generation Orviglance

December 23, 2024 4:30 AM

MALMÖ, SWEDEN / ACCESSWIRE / December 23, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that the Chinese patent authorities have granted patent protection for the second-generation Orviglance®The new patent covers the effervescent tablet formulation of Orviglance. This formulation makes it even easier for patients and...

Read more
PMD Device Solutions AB (publ) has Filed for Bankruptcy
Healthcare & PharmaceuticalRegulatory

PMD Device Solutions AB (publ) has Filed for Bankruptcy

December 22, 2024 10:10 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / December 22, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The Board of PMD Device Solutions AB (publ) has today filed for bankruptcy following extensive reviews of the company's financial position. The bankruptcy filing will be submitted to the Stockholm District Court on December 22, 2024, in parallel with the bankruptcy filing of its Irish subsidiary, PMD Device Solutions Limited.The Board's decision follows...

Read more
Quantum Biopharma Announces Closing of Second Tranche
Healthcare & PharmaceuticalCompany Update

Quantum Biopharma Announces Closing of Second Tranche

December 20, 2024 7:30 PM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that it has closed a second tranche ("Second Tranche") of the offering announced on December 5, 2024 (the "December 5 NR") and has issued 500 Debenture Units (as defined in the December 5 NR) for $500,000.The Company will use the proceeds from the Second Tranche for the ongoing development of the Company's business model and...

Read more
Empowered Roads Reveals 2025 Coaching Industry Trends Report
Healthcare & PharmaceuticalCompany Update

Empowered Roads Reveals 2025 Coaching Industry Trends Report

December 20, 2024 3:00 PM

Empowered Roads, a pioneering wellness coaching company specializing in supporting highly driven women with rheumatoid arthritis and autoimmune conditions, announced its comprehensive "2025CoachingTrends" report. The study highlights the evolution of the coaching industry and high-ticket coaching services. "The coaching industry has transformed dramatically over the past five years," said Lauren Goldstein, founder of Empowered Roads and...

Read more
Pioneers in Pediatrics
Healthcare & PharmaceuticalCompany Update

Pioneers in Pediatrics

December 20, 2024 3:00 PM

Thousands of children throughout Oklahoma are facing pediatric diseases that impact their daily lives. The Children's Health Foundation of Oklahoma (CHF) was founded to support sick children and their families through funding research, education, and care across all of Oklahoma's 77 counties. Since 1982, the organization has raised more than $161 million for patients, and 75% of the state's pediatricians are currently supported by CHF.This...

Read more
Johanna Altman Unveils
Healthcare & PharmaceuticalCompany Update

Johanna Altman Unveils "Pure Wellness Podcast" - Revolutionizing Holistic Health Conversations

December 20, 2024 2:30 PM

Johanna Altman, a renowned figure in the wellness industry and a passionate advocate for holistic health, is thrilled to announce the launch of her brand-new podcast, "Pure Wellness Podcast." This groundbreaking series is designed to enlighten, inspire, and empower listeners by diving deep into the realms of integrative and regenerative medicine, overall health, nutrition, and fitness.Hosted by Johanna Altman, along with occasional guest...

Read more
121 Local & Regional EHR Vendors Across 53 Countries to Know: Showcasing Global Health IT Achievements With Insights From Black Book Research
Healthcare & PharmaceuticalCompany Update

121 Local & Regional EHR Vendors Across 53 Countries to Know: Showcasing Global Health IT Achievements With Insights From Black Book Research

December 20, 2024 2:30 PM

Black Book Research has conducted an unprecedented global survey, gathering insights from users of local and regional Electronic Health Record (EHR) vendors and Health Information Technology (HIT) support service providers. This extensive study evaluated 121 vendors across 53 countries and territories exclusive of the United States, offering a comprehensive overview of the current EHR landscape.Over the past decade, the EHR market has...

Read more
Mentavi Health Offers Tips and Tools to Help Manage Stress During the Holiday Season
Healthcare & PharmaceuticalCompany Update

Mentavi Health Offers Tips and Tools to Help Manage Stress During the Holiday Season

December 20, 2024 12:35 PM

For many, the days leading up to the holidays aren't always merry and bright. In fact, a 2023 survey by the American Psychological Association found that 89% of U.S. adults feel stressed during the holiday season, with 41% reporting higher stress levels compared to other times of the year. Mentavi Health, leader in providing mental health diagnosis and treatment through Mentavi and ADHD Online, is sharing a variety of helpful tips and tools to...

Read more
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Healthcare & PharmaceuticalCompany Update

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

December 20, 2024 9:15 AM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased USD $1,000,000 Bitcoin (BTC) and other cryptocurrencies as part of its strategic efforts. As well, going forward the Company will allow for future financing and other transactions to be carried out in cryptocurrency.This move reflects the...

Read more
American Health Imaging Brings State-of-Art Medical Imaging to the Greater Huntsville Area
Healthcare & PharmaceuticalCompany Update

American Health Imaging Brings State-of-Art Medical Imaging to the Greater Huntsville Area

December 20, 2024 9:00 AM

American Health Imaging (AHI), a leader in advanced outpatient diagnostic imaging services, is pleased to announce an expansion into the greater Huntsville, Alabama area with the recent opening of two new multi-modality diagnostic imaging centers in Huntsville and Madison. The state-of-the-art facilities are dedicated to providing high-quality imaging services at affordable costs, and with a strong focus on patient comfort and...

Read more
Top Healthcare IT Vendors Driving Interoperability and Transforming Care Delivery in Brazil, India, Singapore, South Africa, and Italy: Black Book Research
Healthcare & PharmaceuticalCompany Update

Top Healthcare IT Vendors Driving Interoperability and Transforming Care Delivery in Brazil, India, Singapore, South Africa, and Italy: Black Book Research

December 20, 2024 7:30 AM

Black Book Research, a leading healthcare IT market research firm, has released its latest rankings on interoperability leadership among tech vendors, EHR providers, and population health software companies operating outside the United States. The findings highlight the global leaders in enabling seamless data exchange across healthcare systems, showcasing the significant strides made by vendors in regions with diverse and often challenging...

Read more
ZuriMED Secures FDA Clearance for the FiberLocker(R) System
Healthcare & PharmaceuticalProduct Announcements

ZuriMED Secures FDA Clearance for the FiberLocker(R) System

December 20, 2024 4:40 AM

The Swiss MedTech startup ZuriMED Technologies AG is pleased to announce FDA clearance of its FiberLocker® System, a cutting-edge solution for rotator cuff repair reinforcement. This milestone marks the upcoming U.S. launch in early 2025 and enables surgeons to leverage this novel technology for rotator cuff repair procedures.Just in time for the holiday season, ZuriMED Technologies AG celebrated a significant achievement: FDA clearance of their...

Read more
The Year in Review: Reflections from iZafe Group’s CEO on 2024
Healthcare & PharmaceuticalCompany Update

The Year in Review: Reflections from iZafe Group’s CEO on 2024

December 20, 2024 3:30 AM

STOCKHOLM, SE / ACCESSWIRE / December 20, 2024 / iZafe Group (STO:IZAFE-B) 2024 has been a transformative year for iZafe Group, where we have laid a strong foundation for the future. We have multiplied our net revenue, delivered over 500 Dosell units to Spain, and are approaching 2,000 units in the Netherlands. The number of units that deliver the right medication at the right time daily has increased by approximately 500% compared to 2023,...

Read more
Supporting Elderly Health: The Role of Orthopaedic Care
Healthcare & PharmaceuticalCompany Update

Supporting Elderly Health: The Role of Orthopaedic Care

December 19, 2024 8:00 PM

SINGAPORE / ACCESSWIRE / December 19, 2024 / The Singapore population is aging rapidly, and thus the health needs of the elderly population are more pressing than ever. At The Orthopaedic and Pain Practice, we understand the importance of seniors being able to live comfortably and without pain, so we offer specialised orthopaedic care. Our goal is to help the elderly in our community to continue to live healthy and mobile lives by delivering...

Read more
Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025
Healthcare & PharmaceuticalCompany Update

Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025

December 19, 2024 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a company overview at the 43rd Annual J.P. Morgan Healthcare Conference taking place January 12-16, 2025 in San Francisco, CA. The Company will also participate in one-on-one meetings.43rd Annual J.P. Morgan Healthcare Conference - January 12-16, 2025Format: Company PresentationDay/Time:...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?